Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-1β (rs 1143627 T/C) Gene Polymorphism May Increase the Risk of Developing Lumbar Degenerative Disc Disease in Turkish Population: A Preliminary Study

NCT05601739 is registered in ClinicalTrials.gov with Yeditepe University as lead sponsor.

NCT NCT05601739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-1β (rs 1143627 T/C) Gene Polymorphism May Increase the Risk of Developing Lumbar Degenerative Disc Disease in Turkish Population: A Preliminary Study
Lead sponsor
Yeditepe University
Phase
Observational
Overall status
Completed
Start date
April 8, 2019
Completion date
April 3, 2020
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, low back pain, lumbar disc degeneration